Company
MiNK Therapeutics, Inc. (INKT)
Standardized SEC financial data for MiNK Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001840229 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
87.8%
Free cash flow
-$6.0M
Current ratio
1.06×
EPS (diluted)
$-2.93
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $9.5M | $14.0M | $23.1M | $15.5M | $6.3M | $5.8M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.7M | $38.9M | $19.6M | $3.4M | $4.6M | $13.4M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$8.3M | -$12.8M | -$18.9M | -$15.8M | -$9.6M | -$5.9M |
| Capital expenditures |
Get INKT data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INKT/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INKT/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"